This legislation extends the requirement for annual briefings on the National Biodefense Strategy to five years after the enactment of the National Defense Authorization Act for Fiscal Year 2027. This ensures continued strategic planning and oversight for the nation's biodefense capabilities. A core provision mandates a comprehensive analysis and recommendations concerning engineering biology risks to U.S. national security and the life science research enterprise. The analysis will assess threats, current biodefense research and development, and evaluate existing authorities and programs for biosafety and biosecurity, identifying gaps and redundancies. Recommendations will focus on aligning research, modernizing regulations, and establishing safeguards to mitigate these risks, including proposed legislative actions and funding estimates. These recommendations are to be developed in consultation with industry, academia, civil society, and other stakeholders, and the final report will be submitted in an unclassified form.